Subacute cutaneous lupus erythematosus induced by terbinafine: Case report and review of literature;Subakut-kutaner lupus erythematodes nach gabe von terbinafin: Ein fallbericht und literaturübersicht

JDDG - Journal of the German Society of Dermatology

Volumn 6, Issue 10, 2008, Pages 823-827

  Lorentz, Katharina ^a   Booken, Nina ^a   Goerdt, Sergij ^a   Goebeler, Matthias ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Drug induced lupus erythematosus; SCLE; Terbinafine

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CICLOPIROXOLAMINE; CREATINE KINASE; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; LA ANTIBODY; LACTATE DEHYDROGENASE; RO ANTIBODY; STEROID; TERBINAFINE;

AGED; ANTIBODY TITER; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; REVIEW; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; TINEA CORPORIS;

EID: 54749111794     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2008.06806.x     Document Type: Review

References (17)

1. Borchers AT, Kleen CL, Gershwin ME. Drug-induced lupus. Ann NY Acad Sci 2007 1108 : 166 182.
2. Antonov D, Kazandjieva J, Etugov D, Gospodinov D, Tsankov N. Drug-induced lupus erythematosus. Clin Dermatol 2004 22 : 157 166.
3. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 1985 103 : 49 51.
4. Murphy M, Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol 1998 138 : 708 709.
5. Brooke A, Coulson IH, Al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998 139 : 1132 1133.
6. Holmes S, Kemmett D. Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol 1998 139 : 1133.
7. Bonsmann G, Schiller M, Luger T, Ständer S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001 44 : 925 931.
8. Hill VA, Chow J, Cowley N, Marsden RA. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol 2003 148 : 1056.
9. McKay DA, Schofield MV, Benton EC. Terbinafine-induced subacute cutaneous lupus erythematosus. Acta Derm Venereol 2004 84 : 472 474.
10. Callen JP, Highes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine. Arch Dermatol 2001 137 : 1196 1698.
11. McKellar G, Porter D, Burden D. Terbinafine as a cause of cutaneous lupus erythematosus. Rheumatology (Oxford) 2004 43 : 249.
12. Matthes T, Hagedorn M. Terbinafin-induzierter subakut-kutaner Lupus erythematodes. Hautarzt 2004 55 : 653 657.
13. Terrab Z, El Ouzzani T, Zouhair K, El Kabli H, Lakhdar H. Syndrome de Stevens-Johnson et aggravation d'un lupus systémique induits par la terbinafine. Ann Dermatol Venereol 2006 133 : 463 466.
14. Farhi D, Viguier M, Cosnes A, Reygagne P, Dubertret L, Revuz J, Roujeau JC, Bechelez H. Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology 2006 212 : 59 65.
15. Cetkowská P, Pizinger K. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Int J Dermatol 2006 45 : 320 322.
16. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Brit J Dermatol 1992 126 Suppl 39 : 2 7.
17. ® Fachinformation, Rote Liste Service GmbH, Berlin, Oktober 2006.